To receive issues of Hypertension News directly in your inbox, please join the ISH.
It is possible to join the ISH for free as an Associate Member. Membership for trainees also comes atno cost.
We are delighted to share with you the December 2024 issue of Hypertension News.
GEORGE STERGIOU (GREECE)
Franz Volhard Award Lecturer: Translating the genetics of blood pressure: STEPHEN HARRAP (AUSTRALIA)
New Investigator Award Winners:
Exploring the potential of renal denervation in heart failure therapy: new insights into right ventricular function and sympathetic nervous modulation: MATÚŠ MIKLOVIČ (CZECH REPUBLIC)
The ISH Capacity Building Network at ISH2024: DEAN PICONE (Australia), NIAMH CHAPMAN (Australia) AND LEBO GAFANE-MATEMANE (South Africa)
The speed mentoring fostered immediate connections and set the groundwork for long-term mentorship opportunities: ZITANDILE MFONO (SOUTH AFRICA)
Membership committee at ISH2024
Mitigating pre-eclampsia risk: an integrated approach: MARIANE BERTAGNOLLI (CANADA)
Innovations for improving hypertension and cardiovascular disease risk management in primary care: ANDRES ROSENDE AND PEDRO ORDUNEZ (USA)
New ISH position paper published on latest technology in BP measurement: KAZUOMI KARIO (Japan)
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030: ALTA SCHUTTE AND MARKUS SCHLAICH (Australia)
War-induced stress and arterial hypertension: a prospective study among Ukrainian refugee women: ANNA SHALIMOVA (POLAND), M. S. STOENOIU (BELGIUM), W.J. CUBAŁA (POLAND), M. BURNIER (SWITZERLAND), A. PERSU (BELGIUM), K. NARKIEWICZ (POLAND)
The association between hypertension and Alzheimer’s disease: MATT LENNON (AUSTRALIA)
Ethnic differences in knowledge, attitudes, and practices related to dietary salt intake and association with hypertension in Malaysia: a multi-center cross-sectional study: YOOK-CHIN CHIA (MALAYSIA)
Antihypertensive treatment improves target organ damage in patients with masked hypertension: YAN LI AND JI-GUANG WANG (CHINA)
The incidence of new-onset hypertension and new-onset Type 2 diabetes during or after SARS-CoV-2 infection: ABHINAV GUPTA (INDIA)
The development of a ‘chatbot’ for management of hypertension in Pakistan: MOHAMMAD ISHAQ (PAKISTAN)
